Elanco Animal Health Incorporated (ELAN) Financial Statements

Executive TeamFinancials
SegmentsShareholders

Elanco Animal Health financial statements at a glance

Elanco Animal Health reported revenue of $4.72 billion for fiscal year 2025 (ended December 31, 2025), up 6.2% from fiscal year 2024. Net income was -$232.00 million, a net margin of 4.9% loss, and diluted earnings per share were -$0.47.

At the end of fiscal year 2025 it had total assets of $13.36 billion, total liabilities of $6.81 billion and shareholders' equity of $6.55 billion, with cash and short-term investments of $545.00 million and total debt of $4.02 billion.

Its operations brought in $560.00 million of cash; capital spending was $276.00 million, leaving free cash flow of $284.00 million.

The tables below show the income statement, balance sheet and cash flow statement; the key figures of the last 5 fiscal years are at the bottom of the page.

Figures from company filings, in USD; latest fiscal year ended December 31, 2025.

ELAN logo

Elanco Animal Health Incorporated

ELANUnited States
Healthcare
USD (Local)

Income Statement

Annual • USD

Total Revenue
4.71B
Prev Year: 4.44B
YoY: +6.2%
Operating Revenue
4.71B
Prev Year: 4.44B
YoY: +6.2%
Normalized EBITDA
913.00M
Prev Year: 895.00M
YoY: +2.0%
Tax Rate for Calcs
0.21
Prev Year: 0
Tax Effect of Unusual Items
-49.77M
Prev Year: 151.90M
YoY: -132.8%
Other Income Expense
-256.00M
Prev Year: 472.00M
YoY: -154.2%
Other Non-operating Income (expense)
-19.00M
Prev Year: -18.00M
YoY: -5.6%
Special Income Charges
-237.00M
Prev Year: 490.00M
YoY: -148.4%
Other Special Charges
8.00M
Prev Year: 7.00M
YoY: +14.3%
Write-offs
39.00M
Impairment of Capital Assets
71.00M
Prev Year: 81.00M
YoY: -12.3%
Restructuring and Mergers Acquisition
119.00M
Prev Year: 62.00M
YoY: +91.9%
Depreciation Amortization Depletion
543.00M
Prev Year: 527.00M
YoY: +3.0%
Depreciation and amortization
543.00M
Prev Year: 527.00M
YoY: +3.0%
Amortization
543.00M
Prev Year: 527.00M
YoY: +3.0%
Amortization of Intangibles
543.00M
Prev Year: 527.00M
YoY: +3.0%
Cost of Revenue
2.12B
Prev Year: 2.00B
YoY: +5.9%
Gross Profit
2.59B
Prev Year: 2.44B
YoY: +6.4%
Operating Expense
2.34B
Prev Year: 2.19B
YoY: +7.1%
Selling General and Administrative
1.43B
Prev Year: 1.31B
YoY: +8.8%
Research and Development
368.00M
Prev Year: 344.00M
YoY: +7.0%
Operating Income
252.00M
Prev Year: 251.00M
YoY: +0.4%
Net Non Operating Interest Income Expense
-220.00M
Prev Year: -235.00M
YoY: +6.4%
Non-operating Interest Expense
220.00M
Prev Year: 235.00M
YoY: -6.4%
Pre-tax Income
-224.00M
Prev Year: 488.00M
YoY: -145.9%
Provision for Income Taxes
8.00M
Prev Year: 150.00M
YoY: -94.7%
Net Income Common Stockholders
-232.00M
Prev Year: 338.00M
YoY: -168.6%
Net Income
-232.00M
Prev Year: 338.00M
YoY: -168.6%
Net Income Including Non-Controlling Interests
-232.00M
Prev Year: 338.00M
YoY: -168.6%
Net Income from Continuing Operations
-232.00M
Prev Year: 338.00M
YoY: -168.6%
Diluted NI Available to Com Stockholders
-232.00M
Prev Year: 338.00M
YoY: -168.6%
Basic EPS
-0.47
Prev Year: 0.68
YoY: -169.1%
Diluted EPS
-0.47
Prev Year: 0.68
YoY: -169.1%
Weighted Average Shares (basic)
496.40M
Prev Year: 494.00M
YoY: +0.5%
Weighted Average Shares (diluted)
496.40M
Prev Year: 497.30M
YoY: -0.2%
Total Expenses
4.46B
Prev Year: 4.19B
YoY: +6.6%
Net Income from Continuing and Discontinued Operation
-232.00M
Prev Year: 338.00M
YoY: -168.6%
Normalized Income
-44.77M
Prev Year: -100.0K
YoY: -44670.0%
Interest Expense
220.00M
Prev Year: 235.00M
YoY: -6.4%
Net Interest Income
-220.00M
Prev Year: -235.00M
YoY: +6.4%
EBIT
-4.00M
Prev Year: 723.00M
YoY: -100.6%
EBITDA
676.00M
Prev Year: 1.39B
YoY: -51.2%
Reconciled Cost of Revenue
1.99B
Prev Year: 1.87B
YoY: +6.3%
Reconciled Depreciation
680.00M
Prev Year: 662.00M
YoY: +2.7%
Net Income from Continuing Operation Net Minority Interest
-232.00M
Prev Year: 338.00M
YoY: -168.6%
Total Unusual Items Excluding Goodwill
-237.00M
Prev Year: 490.00M
YoY: -148.4%
Total Unusual Items
-237.00M
Prev Year: 490.00M
YoY: -148.4%
Values in USD

Elanco Animal Health key figures by fiscal year

FY2025FY2024FY2023FY2022FY2021
Revenue$4.7B$4.4B$4.4B$4.4B$4.8B
Gross profit$2.6B$2.4B$2.5B$2.5B$2.6B
Operating income$252.0M$251.0M$326.0M$384.0M$304.0M
Net income-$232.0M$338.0M-$1.2B-$78.0M-$483.0M
Diluted EPS-$0.47$0.68-$2.50-$0.15-$0.97
Total assets$13.4B$12.6B$14.4B$15.5B$16.5B
Total liabilities$6.8B$6.5B$8.1B$8.2B$9.0B
Shareholders' equity$6.5B$6.1B$6.2B$7.3B$7.5B
Cash and short-term investments$545.0M$468.0M$352.0M$345.0M$638.0M
Total debt$4.0B$4.3B$5.8B$5.8B$6.3B
Operating cash flow$560.0M$541.0M$271.0M$452.0M$483.0M
Capital spending$276.0M$161.0M$154.0M$184.0M$197.0M
Free cash flow$284.0M$380.0M$117.0M$268.0M$286.0M

In USD. Fiscal years as reported by the company; statements on this page go back to fiscal year 2015.

Questions and answers

What was Elanco Animal Health's revenue in fiscal year 2025?

$4.72 billion, up 6.2% from $4.44 billion in fiscal year 2024.

How much profit does Elanco Animal Health make?

Elanco Animal Health reported net income of -$232.00 million for fiscal year 2025 (4.9% of revenue); operating income was $252.00 million.

How much cash and debt does Elanco Animal Health have?

At the end of fiscal year 2025: cash and short-term investments of $545.00 million and total debt of $4.02 billion.

What is Elanco Animal Health's free cash flow?

$284.00 million in fiscal year 2025 (operating cash flow of $560.00 million minus capital spending of $276.00 million).

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.
LinkedInLinkedInXXYouTubeYouTube